The changes and clinical significance of human epididymis secretory protein 4 (HE4) and CA125 during perioperative ovarian cancer
Liye Fu,Xin Tian,Yan Li,Fandong Meng,Tao Jiang,Youhong Jiang
DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.20.023
2017-01-01
Journal of Modern Oncology
Abstract:Objective:To monitor the changes of human epididymis secretory protein 4 (HE4),and CA125 (carbohydrate antigen 125) of ovarian cancer patients before and after surgery,to analyze the value of HE4 and CA125 in the diagnosis and treatment of ovarian cancer.Methods:The data of 180 patients with ovarian cancer were selected,according to clinical stage,they were divided into early group (90 cases) and middle-late group (90 cases),90 cases with benign ovarian disease as benign group and 90 cases of healthy adult women were selected as control group.The serum HE4 and CA125 expression level were monitored respectively before and after the surgery,to count and analyze the value of different testing methods for diagnosing,and the ovarian cancer patients were followed up for 12 months,the serum HE4 and CA125 of recurrence patients and patients without recurrence before and after surgery were analyzed.Results:The serum HE4 and CAt 25 specific degree were 98.89%,positive predictive value (99.27%) was significantly higher than that of HE4 separate detection and CA125 separate detection,P < 0.05,there was statistical difference between groups.After the surgery,serum HE4 and CA125 of ovarian cancer patients were significantly decreased (P < 0.05),but,in the same spot,ovarian cancer serum HE4 and CA125 were significantly higher than the control group and benign group (P < 0.05),and serum HE4 in middle-late group was significantly higher than early group (P < 0.05),and the serum HE4 and CA125 in benign group were slightly higher than the control group,there were no significant differences between groups (P > 0.05).For the ovarian cancer relapses patients,serum HE4 and CA125 were significantly higher than the group without recurrence,P < 0.05,there was statistically significant.Conclusion:The serum CA125 and HE4 abnormally elevate significantly in ovarian cancer patients,combined detection of serum HE4 and CA125 can promote the early diagnosis of ovarian cancer specificity and positive accuracy and can also provide reliable information for prognostic assessment.